Cargando…

Unrecognized severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare personnel in a low-prevalence area

Detalles Bibliográficos
Autores principales:	Shah, Vishal P., Hainy, Caitlin M., Swift, Melanie D., Breeher, Laura E., Theel, Elitza S., Sampathkumar, Priya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737134/ https://www.ncbi.nlm.nih.gov/pubmed/33213552 http://dx.doi.org/10.1017/ice.2020.1341

Ejemplares similares

Multiple SARS-CoV-2 Reinfections: A Case Series of Thrice-Infected Individuals
por: Swift, Melanie D., et al.
Publicado: (2022)

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel
por: Swift, Melanie D, et al.
Publicado: (2021)

Revisiting the Safety of Health Care Workers
por: Breeher, Laura E., et al.
Publicado: (2020)

COVID-19 Infections in Health Care Personnel by Source of Exposure and Correlation With Community Incidence
por: Wight, Elizabeth, et al.
Publicado: (2022)

Disparities in COVID-19 vaccine uptake among health care workers
por: Farah, Wigdan, et al.
Publicado: (2022)

A Framework for Sustainable Contact Tracing and Exposure Investigation for Large Health Systems
por: Breeher, Laura, et al.
Publicado: (2020)

Who is getting boosted? Disparities in COVID-19 vaccine booster uptake among health care workers
por: Farah, Wigdan, et al.
Publicado: (2023)

Healthcare personnel absenteeism, presenteeism, and staffing challenges during epidemics
por: Challener, Douglas W., et al.
Publicado: (2020)

Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel
por: Tande, Aaron J, et al.
Publicado: (2022)

Hybrid Immunity Provides Protective Advantage Over Vaccination or Prior Remote Coronavirus Disease 2019 Alone
por: Virk, Abinash, et al.
Publicado: (2023)

Performance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization: A Review
por: Theel, Elitza S.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus 2 seroprevalence among personnel in the healthcare facilities of Croatia, 2020
por: Vilibic-Cavlek, Tatjana, et al.
Publicado: (2020)

Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
por: Misra, Anisha, et al.
Publicado: (2022)

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence in healthcare personnel in northern California early in the coronavirus disease 2019 (COVID-19) pandemic
por: Rosser, Joelle I., et al.
Publicado: (2020)

Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products
por: Manian, Deepti Vellaichamy, et al.
Publicado: (2021)

Reducing Community Exposure to Protect Health Care Personnel in a Pandemic Environment
por: Breeher, Laura E.
Publicado: (2021)

Prevalence of SARS-CoV-2 Antibodies in a Multistate Academic Medical Center
por: Carter, Rickey E., et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence among healthcare personnel at a large health system in Atlanta
por: Graciaa, Daniel S., et al.
Publicado: (2022)

Precautions, Utilization of Personal Protective Equipment, and Conservation Strategies During the COVID-19 Pandemic
por: Sampathkumar, Priya, et al.
Publicado: (2020)

Screening for SARS-CoV-2: Health Policy Implications in Low- and Middle-Income Countries
por: Hashmi, Shahrukh K., et al.
Publicado: (2020)

Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare personnel in the Midwestern United States, September 2020–April 2021
por: Bosserman, Rachel E., et al.
Publicado: (2023)

SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel, Detroit Metropolitan Area, Michigan, USA, May–June 2020
por: Akinbami, Lara J., et al.
Publicado: (2020)

Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2
por: Theel, Elitza S., et al.
Publicado: (2020)

A Multidimensional Cross-Sectional Analysis of Coronavirus Disease 2019 Seroprevalence Among a Police Officer Cohort: The PoliCOV-19 Study
por: Sendi, Parham, et al.
Publicado: (2021)

Molecular and Direct Detection Tests for Treponema pallidum Subspecies pallidum: A Review of the Literature, 1964–2017
por: Theel, Elitza S, et al.
Publicado: (2020)

Large-Scale Testing of Asymptomatic Healthcare Personnel for Severe Acute Respiratory Syndrome Coronavirus 2
por: Hogan, Catherine A., et al.
Publicado: (2021)

Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening
por: Tande, Aaron J, et al.
Publicado: (2021)

Autoimmune Encephalitis After SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes
por: Valencia Sanchez, Cristina, et al.
Publicado: (2021)

SARS-CoV-2 Seroprevalence and Symptom Onset in Culturally Linked Orthodox Jewish Communities Across Multiple Regions in the United States
por: Zyskind, Israel, et al.
Publicado: (2021)

Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya
por: Etyang, Anthony O, et al.
Publicado: (2021)

Seroprevalence of Helicobacter pylori Infection in Korean Health Personnel
por: Kim, Hyun Young, et al.
Publicado: (2013)

Diagnostic Testing for Zika: Observing Rapid Translation During a Public Health Emergency
por: Kurani, Shaheen, et al.
Publicado: (2017)

What are the sources of exposure in healthcare personnel with coronavirus disease 2019 infection?
por: Zabarsky, Trina F., et al.
Publicado: (2021)

451. Evaluation of Exposure History in Healthcare Personnel with Coronavirus 2019 Disease
por: Silva, Sandra, et al.
Publicado: (2020)

Minimal Population Prevalence and Mortality of Coronavirus Disease 2019 in Healthcare Personnel
por: Gupta, Kalpana, et al.
Publicado: (2020)

The Role of Antibody Testing for SARS-CoV-2: Is There One?
por: Theel, Elitza S., et al.
Publicado: (2020)

Guide to Understanding the 2019 Novel Coronavirus
por: Shah, Aditya, et al.
Publicado: (2020)

Mass severe acute respiratory coronavirus 2 (SARS-CoV-2) testing of asymptomatic healthcare personnel – ERRATUM
por: Roberts, Scott C., et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19—Nashville, Tennessee
por: Stubblefield, William B, et al.
Publicado: (2020)

339. Assessing Utilization of the Venereal Disease Research Laboratory Test in Cerebrospinal Fluid for the Diagnosis of Neurosyphilis: A Cohort Study
por: Sytsma, Terin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bgpfuhq99o59kl3jcketrlu86j